New Possibilities in Molecular Diagnosis and Prognosis of Diseases Associated with Human Papilloma Virus in Cervical Secretion
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The aim of the article is to determine the importance of the systematic analysis of data available in modern publications – molecular markers of cervical discharge in the diagnosis of various diseases of the cervix associated with human papilloma virus (HPV). In addition, the prospects of studying protein and metabolic profiles of cervicovaginal discharge for predicting the course of neoplastic processes of the cervix. The article describes a number of protein markers in cervical defined for the early diagnosis of precancerous diseases and cervical cancer.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Venkataraman N. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid / A.L. Cole, P. Svoboda, J. Pohl, A.M. Cole // J. Immunol. – 2005. – V. 175 (11). – P. 7560-7.
Di Quinzio M.K. Proteomic analysis and characterisation of human cervico-vaginal fluid proteins / K. Oliva, S.J. Holdsworth, M. Ayhan, S.P. Walker, G.E. Rice et al. //Aust. N. Z. J. Obstet. Gynaecol. – 2007. – V. 47 (1). – P. 9-15.
Heng Y.J. Interleukin-1 receptor antagonist in human cervicovaginal fluid in term pregnancy and labor /M.K. Di Quinzio, M. Permezel, G.E. Rice, H.M. Georgiou // Am. J. Obstet. Gynecol. – 2008. – V. 199 (6). – P. 656-73. e1-7.
Dasari S. Comprehensive proteomic analysis of human cervical-vaginal fluid // L. Pereira, A.P. Reddy, J.E. Michaels, X. Lu, T. Jacob et al. // J. Proteome Res. – 2007. – V. 6 (4). – P. 1258-68.
Shaw J.L. Proteomic analysis of human cervico-vaginal fluid / C.R. Smith, E.P. Diamandis // J. Proteome Res. – 2007. – V. 6 (7). – P. 2859-65.
Tang L.J. Proteomic analysis of human cervical-vaginal fluids / S.F. De, F. Odreman, P. Venge, C. Piva, S. Guaschino, R.C. Garcia // J. Proteome Res. – 2007. – V. 6 (7). – P. 2874-83.
Zegels G. Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples / G.A. Van Raemdonck, E.P. Coen, W.A. Tjalma, X.W. Van Ostade // Proteome Sci. – 2009. – V. 7. – P. 17.
Andersch-Bjorkman Y. Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle / K.A. Thomsson, J.M. Holmen Larsson, E. Ekerhovd, G.C. Hansson // Mol. Cell. Proteomics. – 2007. – V. 6 (4). – P. 708-16.
Panicker G. Characterization of the human cervical mucous proteome / Y. Ye, D. Wang, E.R. Unger // Clin. Proteomics. – 2010. – V. 6 (1–2). – P. 18-28.
Ding T. Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women / X. Wang, F. Ye, X. Cheng, D. Ma, W. Lu, X. Xie // Gynecol. Oncol. – 2010. – V. 119 (3). – P. 436-43.
Zardiashvili M.D. Molecular markers of cervicovaginal fluid: a new in the diagnosis and prognosis of diseases associated with human papilloma virus / N.M. Nazarova, N.L. Starodubtseva, A.E. Bugrova, E. Frankevich, V.N. Prilepskaya // Obstetrics and gynecology. – 2016. – V. 1. – P. 16-21.
Van Ostade X. Analysis of cervico-vaginal fluid from precancerous women points to the presence of biomarkers for the precancerous state of cervical carcinoma / D. Martin, G. Raemdonck // Proteomes. – 2014. – V. 2 (3). – P. 426-50. doi: 10.3390/proteomes2030426.
Schiffman M. Human papillomavirus and cervical cancer // P.E. Castle, J. Jeronimo, A.C. Rodriguez, S. Wacholder // Lancet. – 2007. – V. 370 (9590). – V. 890-907.
Kroeger K.M. The 308 tumor necrosis factor-alpha promoter polymorphism effects transcription / K.S. Carville, L.J. Abraham // Mol. Immunol. – 1997. – V. 34 (5). – P. 391-9.
Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers – United States, 2004–2008 // MMWR Morb. Mortal Wkly Rep. – V. 61 (15). – P. 258-61.
Guidelines for the diagnosis and treatment of human papillomavirus infections of the female genital tract. The official publication of the European Society for infectious diseases in obstetrics and gynecology // European J. Inr. Immunol. Dis. Obstet. Gynaecol. – 2001. – V. 4, 5. – Suppl. 21.
Wheeler C.M. Human papillomavirus genotypes and the cumulative 2-years risk of cervical precancer / W.C. Hunt, M. Schiffman, P.E. Castle // J. Infect. Dis. – 2006. – V. 194 (9). – P. 1291-9.
Van Raemdonck G.A. Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid / W.A. Tjalma, E.P. Coen, C.E. Depuydt, X.W. Van Ostade // PLoS One. – 2014. – V. 9 (9). – P.e106488.
Scheffner M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 / M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, P.M. Howley // Cell. – 1990. – V. 63 (6). – P. 1129-36.
Roman A. The papillomavirus E7 proteins / A. Roman, K. Munger // Virology. – 2013. – V. 445 (1–2). – P. 138-68.
Ullal A. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia / M. Roberts, J.N. Bulmer, M.E. Mathers, V. Wadehra // Cytopathology. – 2008. – V. 20 (6). – P. 359-66.
Pereira P.M. MicroRNA expression variability in human cervical tissues / J.P. Marques, A.R. Soares, L. Carreto, M.A. Santos // PLoS One. – 2010. – V. 5 (7). – P.e11780.
Quayle A.J. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J. Reprod. Immunol. – 2002. – V. 57(1–2). – P. 61-79.
Ochiel D.O. Innate immunity in the female reproductive tract: role of sex hormones in regulating uterine epithelial cell protection against pathogens / J.V. Fahey, M. Ghosh, S.N. Haddad, C.R. Wira // Curr Womens Health Rev. – 2008. – V. 4 (2). – P. 102-17.
Iijima N. Dendritic cells and macrophages in the genitourinary tract / J.M. Thompson, A. Iwasaki // Mucosal Immunol. – 2008. – V. 1 (6). – P. 451-9.
Eschenbach D.A. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora / S.S. Thwin, D.L. Patton, T.M. Hooton, A.E. Stapleton, K. Agnew et al. // Clin. Infect. Dis. – 2000. – 30 (6). – P. 901-7.
Valore E.V. Antimicrobial components of vaginal fluid / C.H. Park, S.L. Igreti, T. Ganz // Am. J. Obstet. Gynecol. – 2002. – V. 187 (3). – P. 561-8.
Cole A.M. Innate host defense of human vaginal and cervical mucosae / Curr. Top. Microbiol. Immunol. – 2006. – V. 306. – P. 199-230.
Rohan L.C. Vaginal drug delivery systems for HIV prevention / A.B. Sassi // AAPS J. – 2009. – V. 11 (1). – P. 78-87.
Wira C.R. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection / K.S. Grant-Tschudy, M.A. Crane-Godreau //Am. J. Reprod. Immunol. – 2005. – V. 53 (1). – P. 65-76.
Klein L.L. Shotgun proteomic analysis of vaginal fluid from women in late pregnancy / K.R. Jonscher, M.J. Heerwagen, R.S. Gibbs, J.L. McManaman // Reprod. Sci. – 2008. – V. 15 (3). – P. 263-73.
Zegels G. Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract / G.A. Van Raemdonck, W.A. Tjalma, X.W. Van Ostade // Proteome Sci. – 2010. – V. 8. – P. 63.
Thomas P.D., PANTHER: a library of protein families and subfamilies indexed by function / M.J. Campbell, А. Kejariwal, Н. Mi, В. Karlak, R. Daverman et al. // Genome Res. 2003. – V. 13 (9). – P. 2129-41.
Good D.M. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future / V. Thongboonkerd, J. Novak, J.L. Bascands, J.P. Schanstra, J.J. Coon et al. // J. Proteome Res. – 2007. – V. 6 (12). – P. 4549-55.
Veenstra T.D. Biomarkers: mining the biofluid proteome / T.P. Conrads, B.L. Hood, A.M. Avellino, R.G. Ellenbogen, R.S. Morrison // Mol. Cell. Proteomics. – 2005. – V. 4 (4). – P. 409-18.
Hu S. Human body fluid proteome analysis / J.A. Loo, D.T. Wong // Proteomics. – 2006. – V. 6 (23). – P. 6326-53.
Schmidt A. High-accuracy proteome maps of human body fluids / R. Aebersold // Genome Biol. – 2006. – V. 7 (11). – P. 242.
Novak R.M. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection / B.A. Donoval, P.J. Graham, L.A. Boksa, G. Spear, R.C. Hershow et al. // Clin. Vaccine Immunol. – 2007. – V. 14 (9). – P. 1102-7.
Wiesenfeld H.C. Association between elevated neutrophil defensin levels and endometritis / R.P. Heine, M.A. Krohn, S.L. Hillier, A.A. Amortegui, M. Nicolazzo, R.L. Sweet // J. Infect. Dis. – 2002. – V. 186 (6). – P. 792-7.
Xu J. Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery / C.B. Holzman, C.G. Arvidson, H. Chung, A.R. Goepfert // Obstet. Gynecol. – 2008. – V. 112 (3). – P. 524-31.
St John E. Bacterial vaginosis and host immunity / D. Mares, G.T. Spear // Curr. HIV/AIDS Rep. – 2007. – V. 4 (1). – P. 22-8.
Spear G.T. Bacterial vaginosis and human immunodeficiency virus infection / E. St John, M.R. Zariffard // AIDS Res. Ther. – 2007. – V. 4. – P. 25.
Wira C.R. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle / J.V. Fahey // AIDS. – 2008. – V. 22 (15). – P. 1909-17.
Meng W. Human в-defensin messenger RNA is overexpressed in the cervical epithelia of patients with non-gonococcal cervicitis / R. Du, Y. Wang, Z. Chen, Y. Ding // J. Low Genit. Tract. Dis. – 2013. – V. 17 (4). – P. 440-5.
Shimoya K. Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women / Q. Zhang, K. Temma, T. Kimura, T. Tsujie, T. Tsutsui at al / Maturitas. – 2006. – V. 54 (2). – P. 141-8.
Ildgruben A. Steroid receptor expression in vaginal epithelium of healthy fertile women and influences of hormonal contraceptive usage / I. Sjöberg, M.L. Hammarström, T. Bäckström // Contraception. – 2005. – V. 72 (5). – P. 383-92.
Ildgruben A.K. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium / I.M. Sjöberg, M.L. Hammarström // Obstet. Gynecol. – 2003. – V. 102 (3). – P. 571-82.
Prevention of cervical cancer: a Guide for physicians. – M.: Medpress-inform. – 2007. – P. 56.
Solomon D. The 2001 Bethesda System. Terminaligy for reporting results of cervical cytology / D. Davey, R. Kurman et al. // JAMA. – 2002. – V. 16. – P. 2114-2118.
Ibeanu OA. Molecular pathogenesis of cervical cancer. Cancer Biology and Therapy. – 2011. – V. 11 (3). – P. 295-306.
http://megaslides.com/doc/794253/lekciya-vospalitelnye-zabolevaniya-zhenskih-polovyh-organov
